ACE and chronic kidney disease: RAS inhibitors (RASis; angiotensin‐converting enzyme inhibitors or angiotensin‐receptor blockers) and angiotensin receptor‐neprilysin inhibitors (ARNIs) are beneficial for the management CKD and HF as they can suppress vasoconstriction and reduce blood pressure.42, 43, 44